ReviewPharmaceutics2021

Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications.

Napoleon-Nikolaos Vrettos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.